Vera Therapeutics VERA
NASDAQ VERA
$30.99 -1.30 (-4.03%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vera Therapeutics (VERA) Cash from Financing Activities (2020 - 2026)

Updated

Vera Therapeutics (VERA) reported Cash from Financing Activities of $1.92 million for Q2 2026, down 90.5% from $20.29 million a year earlier and down 51.3% from the prior quarter.

Analysis

Vera Therapeutics (VERA) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Vera Therapeutics' Cash from Financing Activities came in at $292.94 million, down 15.9% year-over-year; for FY2025, it was $308.9 million, down 49.1% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 29.4% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $606.67 million in FY2024 (+354.3%), $133.54 million in FY2023 (+31.0%), $101.93 million in FY2022 (+89.2%) and $53.88 million in FY2021 (-36.8%).
  • Five-year quarterly Cash from Financing Activities spans a low of $48,000 in Q2 2022 and a high of $325.96 million in Q4 2024.
  • Year over year, Cash from Financing Activities gained in four of the last seven quarters, with growth averaging 85.9%.
  • The high point for year-over-year Cash from Financing Activities in five years was Q2 2023 (growth of 800.0%); the low point was Q2 2022 (a decline of 99.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.94 million (Q1 2026), $286.28 million (Q4 2025) and $797,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Vera Therapeutics 2.33 Bn 2.33 Bn - 1.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.92 Mn
Mar 31, 2026 3.94 Mn
Dec 31, 2025 286.28 Mn
Sep 30, 2025 797,000.00
Jun 30, 2025 20.29 Mn
Mar 31, 2025 1.53 Mn
Dec 31, 2024 325.96 Mn
Sep 30, 2024 739,000.00
Jun 30, 2024 3.44 Mn
Mar 31, 2024 276.54 Mn
Dec 31, 2023 24.83 Mn
Sep 30, 2023 297,000.00
Jun 30, 2023 432,000.00
Mar 31, 2023 107.98 Mn
Dec 31, 2022 20.71 Mn
Sep 30, 2022 908,000.00
Jun 30, 2022 48,000.00
Mar 31, 2022 80.27 Mn
Dec 31, 2021 4.92 Mn
Jun 30, 2021 48.99 Mn
API Access

Vera Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=VERA&period=max&api_key=YOUR_API_KEY